The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK), has announced an intent to publish a funding opportunity, designated as NOT-DK-24-001. This opportunity will focus on research related to the cardiovascular complications of type 1 diabetes (T1D) as part of the NIH Cardiovascular Repository for T1D (CaRe-T1D) Consortium. The initiative is crucial, given that cardiovascular disease (CVD) is a leading cause of death in individuals with T1D, significantly impacting life expectancy.
Eligible applicants for this funding include a broad range of entities, such as educational institutions, government bodies, non-profits, and private sector organizations. The primary goal of this initiative is to establish a biorepository of human cardiovascular tissue and a scientific consortium to advance and support discovery and mechanistic research to enhance understanding of CVD in T1D. This will involve forming a consortium with investigative teams that possess complementary interests and expertise to leverage these resources for individual and collaborative studies. With an expected publication in Fall 2023 and an application due date in Spring 2024, this funding opportunity represents a significant step in advancing knowledge on the pathogenesis of cardiovascular disease in individuals with type 1 diabetes. This research is expected to have a profound impact on the management and treatment of T1D and its cardiovascular complications.
Opportunity ID: 351116
General Information
Document Type: | Grants Notice |
Opportunity Number: | NOT-DK-24-001 |
Opportunity Title: | Notice of Intent to Publish a Funding Opportunity Announcement for Cardiovascular Repository � Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Allowed). |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | |
Expected Number of Awards: | |
CFDA Number(s): | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 1 |
Forecasted Date: | Nov 24, 2023 |
Last Updated Date: | |
Estimated Post Date: | Dec 11, 2023 |
Estimated Application Due Date: | Apr 11, 2024 |
Estimated Award Date: | Dec 02, 2024 |
Estimated Project Start Date: | Dec 02, 2024 |
Fiscal Year: | 2024 |
Archive Date: | |
Estimated Total Program Funding: | |
Award Ceiling: | |
Award Floor: |
Eligibility
Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses For profit organizations other than small businesses Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities County governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for research on�the cardiovascular complications of type 1 diabetes (T1D) as part of the NIH Cardiovascular Repository for T1D (CaRe-T1D).� Cardiovascular disease (CVD) is the leading cause of death for individuals with T1D and significantly shorten their lives.� CaRe-T1D was initiated with the goal of establishing a biorepository of human CV tissue and a scientific consortium to advance and support discovery and mechanistic research that increase the understanding of CVD in T1D.� The first phase launched the biorepository and now in the second phase investigative teams will be added to form a consortium with the biorepository serving as the Coordinating Center (CC).� The goal of the new initiative is to attract investigative teams with complementary interests and expertise who will leverage these resources through individual and collaborative studies to advance our knowledge of the pathogenesis of CVD in T1D.� This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.� The NOFO is expected to be published in Fall 2023 with an expected application due date in Spring 2024. This NOFO will utilize the U01 activity code. Details of the planned NOFO are provided below. |
Link to Additional Information: | |
Grantor Contact Information: |